Prediction of cyclosporine A blood levels: An application of the adaptive-network-based fuzzy inference system (ANFIS) in assisting drug therapy

European Journal of Clinical Pharmacology

Volumn 64, Issue 8, 2008, Pages 807-814

  Gören, Sezer ^a   Karahoca, Adem ^a   Onat, Filiz Y ^b   Gören, M Zafer ^b  

^a BAHCESEHIR UNIVERSITY   (Turkey)

^b MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Adaptive network based fuzzy inference system; Cyclosporine A; Data mining; Fuzzy modeling; Therapeutic drug monitoring

Indexed keywords

CYCLOSPORIN A;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DATA MINING; DRUG BLOOD LEVEL; DRUG MONITORING; EVENING DOSAGE; FEMALE; FUZZY SYSTEM; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; PREDICTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; COMPUTER SIMULATION; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; FUZZY LOGIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MIDDLE AGED; MODELS, BIOLOGICAL; NEURAL NETWORKS (COMPUTER); RETROSPECTIVE STUDIES; SOFTWARE; YOUNG ADULT;

EID: 45849105928     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-008-0490-x     Document Type: Article

References (28)

1. Karaalp A, Demir D, Gören MZ et al (2004) Therapeutic drug monitoring of immunosuppressant drugs in Marmara University Hospital. Ther Drug Monit 26:263-266
2. Aronson JK, Hardman M (1992) Why monitor drug therapy? Br Med J 305:947-948
3. Gross AS (1998) Best practice in therapeutic drug monitoring. Br J Clin Pharmacol 46:95-99
4. Jensen SA, Dalhoff KP (2001) Cyclosporin therapeutic drug monitoring. Transplant Proc 33:3003-3005
5. Cook TLJ (1998) Fever associated with cyclosporine for treating atopic dermatitis. Br Med J 317:1291
6. Wacke R, Rohde B, Engel G (2000) Comparison of several approaches of therapeutic drug monitoring of cyclosporine A based on individual pharmacokinetics. Eur J Clin Pharmacol 56:43-48
7. Camps-Valls G, Oltra BP, Olivas ES et al (2003) Prediction of cyclosporine dosage in patients after kidney transplantation using neural networks. IEEE Trans Biomed Eng 50:442-448
8. Jang JSR (1993) ANFIS: Adaptive-Network-based Fuzzy Inference Systems. IEEE Trans Syst Man Cybern 23:665-685
9. Kannathal N, Choo ML, Rajendra Acharya U et al (2005) Entropies for detection of epilepsy in EEG. Comput Methods Programs Biomed 80:187-194
10. Haykin S (1999) Neural networks: a comprehensive foundation. Prentice Hall, New Jersey
11. Dunham MH (2003) Data mining. Prentice Hall, New Jersey
12. Takagi T, Sugeno M (1985) Fuzzy identification of systems and its applications to modeling and control. IEEE Trans Syst Man Cybern 15:116-132
13. Zadeh LA (1965) Fuzzy sets. Inf Control 8:338-353
14. Elman JL (1988) Finding structure in time. Cogn Sci 14:179-211
15. MATLAB. Available via http://www.mathworks.com/products/matlab
16. Oellerich M, Armstrong VW (2002) Two-hour cyclosporine determination: an appropriate tool to monitor Neoral therapy? Ther Drug Monit 24:40-46
17. Morris RG, Russ GR, Cervelli MJ (2002) Comparison of trough, 2-hour and limited AUC blood sampling for monitoring cyclosporin (Neoral) at day 7 post-renal transplantation and incidence of rejection in the first month. Ther Drug Monit 24:479-486
18. Kasap B, Soylu A, Turkmen M et al (2006) Effect of obesity and overweight on cyclosporine blood levels and renal functions in renal adolescent recipients. Transplant Proc 38:463-465
19. Iwahori T, Takeuchi H, Matsuno N et al (2005) Pharmacokinetic differences between morning and evening administration of cyclosporine and tacrolimus therapy. Transplant Proc 37:1739-1740
20. Aros CA, Schneider HO, Flores CA et al (2005) Correlation between C2 and AUC(0-4) in renal transplant patients treated with diltiazem. Transplant Proc 37:1580-1582
21. Videla C, Vega J, Borja H (2005) Hepatotoxicity associated with cyclosporine monitoring using C2 recommendations in adults renal recipients receiving ketoconazole. Transplant Proc 37:1574-1576
22. Jin M, Shimada T, Yokogawa K et al (2006) Site-dependent contributions of P-glycoprotein and CYP3A to cyclosporin A absorption, and effect of dexamethasone in small intestine of mice. Biochem Pharmacol 72:1042-1050
23. Konishi H, Sumi M, Shibata N et al (2004) Decrease in oral bioavailability of cyclosporin by intravenous pulse of methylprednisolone succinate in rats. J Pharm Pharmacol 56:1259-1266
24. Lehmann JM, Mckee DD, Watson MA et al (1998) The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 102:1016-1023
25. Blumberg B, Sabbagh W Jr, Juguilon H et al (1998) SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes Dev 12:3195-3205
26. Bertilsson G, Heidrich J, Svensson K et al (1998) Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proc Natl Acad Sci USA 95:12208-12213
27. Akira T, Manabu T, Noriyuki K et al (2002) Putative role of the orphan nuclear receptor SXR (Steroid and Xenobiotic Receptor) in the mechanism of CYP3A4 inhibition by xenobiotics. J Biol Chem 277:32453-32458
28. Haufroid V, Mourad M, Van Kerckhove V et al (2004) The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients. Pharmacogenetics 14:147-154